Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 4, Number 1—March 1998

Dispatch

Hantavirus Infection in Children in Argentina

Noemí C. Pini*, Amanda Resa†, Gladys del Jesús Laime‡, Gustavo Lecot¶, Thomas G. Ksiazek§, Silvana Levis*, and Delia A. Enria*
Author affiliations: *Instituto Nacional de Enfermedades Virales Humanas "Dr. Julio I Maiztegui," Pergamino, Argentina; †Hospital de El Bolsón, Río Negro, Argentina; ‡Hospital de Orán, Salta, Argentina; ¶Hospital de Olavarría, Buenos Aires, Argentina; §Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table 2

Laboratory results and clinical features of children with hantavirus infection, Argentina, 1995–1997

Case
Tests and features 1 2 3 4 5
Leukocytes
(/mm3) 9,200 27,000 12,800 10,600 69,200
Hematocrit (%) 44 66 43 55 53
Thrombocytes (/mm3) NDa 266,000 200,000 97,000 ND
Sedimentation rate (mm/hr) ND 4 28 8 1
GOT/GPTb ND Increased Increased Increased Increased (mild)
Chest X-ray HIc DIId DII DII DII
Respiratory symptoms None Distress Slight dyspnea Tachypnea, clinical and X-ray disassociation, hypoventilation Acute respiratory insufficiency

aND: Not done.
bGOT/GPT: Glutamic oxalacetic transaminase/Glutamic pyruvic transaminase.
cHI: Hilar indistinctness.
dDII: Diffuse interstitial infiltrate.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO